Evidence map›Paper›PMID 36079842›Full record

ArticleNutrients2022

Vitamin D Supplementation and COVID-19 Outcomes: Mounting Evidence and Fewer Doubts.

Arrigo F G Cicero, Federica Fogacci, Claudio Borghi

Registry-linked trialAbstract readEditorial
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07254052 (Effectiveness of a Sustained-release Ammonium Chloride Formulation in Reducing the Viral Load of Patients With COVID-19 or Influenza), which is not on this map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07254052 completednot on this mapstarted 2024, after this paper: background citation

Effectiveness of a Sustained-release Ammonium Chloride Formulation in Reducing the Viral Load of Patients With COVID-19 or Influenza

TypeobservationalSponsorNational and Kapodistrian University of AthensRan2024 to 2025Enrolled32ConditionsRNA Virus Infections, Viral Infection COVID-19, Influenza A and B
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Effect of Vitamin D in Long COVID Patients.International journal of environmental research and public health · 2023
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arrigo F G CiceroIRCCS AziendaOspedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0002-4367-3884
Federica FogacciIRCCS AziendaOspedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0001-7853-0042
Claudio BorghiIRCCS AziendaOspedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0001-8039-8781

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) has already killed more than 6 million people around the world. A growing body of epidemiological evidence suggests that low 25-hydroxy vitamin D (25-OH-vitamin D) plasma levels are associated with an increased risk of developing COVID-19 and -most importantly-with a higher risk of developing more severe COVID-19 and dying. On the other hand, vitamin D supplementation during the early phases of COVID-19 has been related to a decreased length of hospital stay, less frequent need for oxygen, and a reduced mortality rate in inpatients. This seems to be particularly true when high dosages are used. In light of this evidence, further studies are needed to define the best timing for vitamin D supplementation and the most effective dosage schedule.

Indexed as

COVID-19Vitamin D DeficiencyDietary SupplementsHumansSARS-CoV-2Vitamin DVitaminsVitamin DVitaminsCholecalciferolCOVID-19immune functionmortalitySARS-CoV-2

Identifiers

PMID36079842
PMCPMC9460517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.